Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Prevention of heart failure.

David W Baker1

  • 1Center for Health Care Research and Policy, Case Western Reserve University at MetroHealth Medical Center, Cleveland, Ohio, USA.

Journal of Cardiac Failure
|November 2, 2002
PubMed
Summary

Preventing heart failure (HF) is crucial as cases rise. Effective treatments for hypertension and high cholesterol significantly reduce HF incidence, yet remain underutilized.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Differences in Performance on Quality Measures for Thrombectomy-Capable Stroke Centers Compared With Comprehensive Stroke Centers in 2019 to 2020.

Stroke (Hoboken, N.J.)·2026
Same author

The Journey Toward Health Care Equity: Accredited Hospitals' Alignment with Joint Commission Health Care Equity Standards Preimplementation.

Health equity·2025
Same author

Transcatheter occlusion of venovenous collaterals in the total cavopulmonary Fontan circulation.

Cardiology in the young·2024
Same author

Clinician Well-Being and Burnout: Panel Interview with Tait Shanafelt, Lisa Rotenstein, and Christine Sinsky.

Joint Commission journal on quality and patient safety·2024
Same author

Handoffs and Care Transitions: Interviews with Chris Landrigan and Theresa Murray.

Joint Commission journal on quality and patient safety·2024
Same author

Letter in response to the letter submitted by Warye et al (AAMI) criticizing the article by Sylvia Garcia-Houchins.

American journal of infection control·2024

Area of Science:

  • Cardiology
  • Preventive Medicine
  • Public Health

Background:

  • Heart failure (HF) incidence is projected to increase significantly due to an aging population in the United States.
  • Urgent improvements in HF prevention strategies are necessary to mitigate this rise.

Purpose of the Study:

  • To identify and evaluate treatments for conditions including hypertension, hypercholesterolemia, asymptomatic left ventricular systolic dysfunction, and diabetes that impact HF incidence.
  • To assess the effectiveness of various therapeutic interventions in reducing the occurrence of heart failure.

Main Methods:

  • Conducted PubMed/MEDLINE searches to identify relevant treatment trials and observational studies.
  • Analyzed data on HF incidence reported in trials for hypertension, hypercholesterolemia, left ventricular systolic dysfunction, and diabetes.

Main Results:

  • Hypertension treatment reduced HF incidence by approximately 50%, with diuretics, beta-blockers, and ACE inhibitors showing greater efficacy.
  • Hydroxymethylglutaryl coenzyme A (HMG CoA) reductase inhibitors reduced HF incidence by about 20% in patients with hypercholesterolemia and coronary artery disease.
  • ACE inhibitors demonstrated significant HF risk reduction in patients with reduced systolic function (37%) and coronary artery disease (23%).
  • Better glycemic control in diabetes correlated with lower HF incidence, though effective therapies are underused, particularly hypertension management.

Conclusions:

  • Clinical trial results indicate substantial potential to reduce HF suffering and economic burden through improved clinical practice.
  • Enhanced control of hypertension, primary prevention of myocardial infarction, and broader adoption of secondary prevention measures are critical for reducing HF prevalence.

Related Experiment Videos